01 4NODEN PHARMA
02 2NOVITIUM PHARMA
01 48618172
02 211878022
01 6Blank
01 6Y
01 42028-07-13
02 22044-01-23
Patent Expiration Date : 2028-07-13
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
US Patent Number : 8618172
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22107
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-07-13
Patent Expiration Date : 2028-07-13
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
US Patent Number : 8618172
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22107
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-07-13
Patent Expiration Date : 2028-07-13
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
US Patent Number : 8618172
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22107
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-07-13
Patent Expiration Date : 2028-07-13
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
US Patent Number : 8618172
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22107
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-07-13
Patent Expiration Date : 2044-01-23
US Patent Number : 11878022
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 219141
Patent Use Code : U-4138
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2044-01-23
Patent Expiration Date : 2044-01-23
US Patent Number : 11878022
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 219141
Patent Use Code : U-4139
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2044-01-23
